A detailed history of Lpl Financial LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lpl Financial LLC holds 1,362,782 shares of NVO stock, worth $116 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,362,782
Previous 1,315,286 3.61%
Holding current value
$116 Million
Previous $188 Million 13.57%
% of portfolio
0.07%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$119.07 - $145.42 $5.66 Million - $6.91 Million
47,496 Added 3.61%
1,362,782 $162 Million
Q2 2024

Aug 07, 2024

BUY
$122.71 - $146.91 $17.3 Million - $20.7 Million
140,671 Added 11.98%
1,315,286 $188 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $24.2 Million - $32.3 Million
237,444 Added 25.34%
1,174,615 $151 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $15.5 Million - $18.6 Million
176,325 Added 23.17%
937,171 $97 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $41.8 Million - $91.7 Million
459,737 Added 152.68%
760,846 $69.2 Million
Q2 2023

Jul 31, 2023

BUY
$155.98 - $172.65 $6.97 Million - $7.72 Million
44,701 Added 17.43%
301,109 $48.7 Million
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $1.99 Million - $2.39 Million
15,026 Added 6.22%
256,408 $40.8 Million
Q4 2022

Feb 07, 2023

BUY
$102.55 - $135.33 $607,301 - $801,424
5,922 Added 2.52%
241,382 $32.7 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $1.58 Million - $1.94 Million
16,562 Added 7.57%
235,460 $23.5 Million
Q2 2022

Aug 12, 2022

SELL
$103.24 - $121.81 $77,017 - $90,870
-746 Reduced 0.34%
218,898 $24.4 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $247,459 - $299,131
2,658 Added 1.22%
219,644 $24.4 Million
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $49,665 - $60,647
-518 Reduced 0.24%
216,986 $24.3 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $2.2 Million - $2.78 Million
26,107 Added 13.64%
217,504 $20.9 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $1.19 Million - $1.49 Million
17,614 Added 10.14%
191,397 $16 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $412,955 - $466,899
6,158 Added 3.67%
173,783 $11.7 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $2.09 Million - $2.42 Million
32,780 Added 24.31%
167,625 $11.7 Million
Q3 2020

Nov 09, 2020

BUY
$63.69 - $70.22 $870,260 - $959,486
13,664 Added 11.28%
134,845 $9.36 Million
Q2 2020

Aug 13, 2020

SELL
$58.54 - $67.94 $590,024 - $684,767
-10,079 Reduced 7.68%
121,181 $7.94 Million
Q1 2020

May 14, 2020

SELL
$49.46 - $64.78 $626,410 - $820,438
-12,665 Reduced 8.8%
131,260 $7.9 Million
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $870,106 - $1.02 Million
-17,451 Reduced 10.81%
143,925 $8.33 Million
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $989,259 - $1.11 Million
20,809 Added 14.8%
161,376 $8.34 Million
Q2 2019

Aug 09, 2019

BUY
$46.79 - $52.47 $769,835 - $863,288
16,453 Added 13.26%
140,567 $7.18 Million
Q1 2019

May 08, 2019

BUY
$46.36 - $52.63 $428,134 - $486,038
9,235 Added 8.04%
124,114 $6.49 Million
Q4 2018

Feb 07, 2019

BUY
$41.54 - $47.25 $1.06 Million - $1.2 Million
25,495 Added 28.52%
114,879 $5.29 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $54,194 - $59,387
1,159 Added 1.31%
89,384 $4.21 Million
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $132,382 - $150,705
-2,989 Reduced 3.28%
88,225 $4.07 Million
Q1 2018

May 15, 2018

BUY
$48.49 - $58.14 $1.73 Million - $2.07 Million
35,587 Added 63.97%
91,214 $4.49 Million
Q4 2017

Feb 14, 2018

SELL
$47.53 - $53.73 $481,954 - $544,822
-10,140 Reduced 15.42%
55,627 $2.99 Million
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $1.33 Million - $1.59 Million
32,285 Added 96.42%
65,767 $3.17 Million
Q2 2017

Aug 14, 2017

BUY
N/A
33,482
33,482 $1.44 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.